Genes & Development · 2019 · 110 citations · 51 references
Life SciencesGeneticsMolecular BiologyDna RepairDna ReplicationRecombinationDna Double-strand Break RepairDna Strand BreaksDouble-strand Break RepairHomologous RecombinationReplication Stress ResponseTelomere MaintenanceAlternative Lengthening Of TelomeresDna Double-strand BreaksDna Repair PathwaysDouble-strand Dna BreaksReplication StressTelomere Damage ResponseTelomere Dna SynthesisTelomere Stability
Approximately 15% of cancers use homologous recombination for alternative lengthening of telomeres (ALT). How the initiating genomic lesions invoke homology-directed telomere synthesis remains enigmatic. Here, we show that distinct dependencies exist for telomere synthesis in response to replication stress or DNA double-strand breaks (DSBs). RAD52 deficiency reduced spontaneous telomeric DNA synthesis and replication stress-associated recombination in G2, concomitant with telomere shortening and damage. However, viability and proliferation remained unaffected, suggesting that alternative telomere recombination mechanisms compensate in the absence of RAD52. In agreement, RAD52 was dispensable for DSB-induced telomere synthesis. Moreover, a targeted CRISPR screen revealed that loss of the structure-specific endonuclease scaffold SLX4 reduced the proliferation of RAD52-null ALT cells. While SLX4 was dispensable for RAD52-mediated ALT telomere synthesis in G2, combined SLX4 and RAD52 loss resulted in elevated telomere loss, unresolved telomere recombination intermediates, and mitotic infidelity. These findings establish that RAD52 and SLX4 mediate distinct postreplicative DNA repair processes that maintain ALT telomere stability and cancer cell viability.
51
Telomere elongation in immortal human cells without detectable telomerase activity.
Tracy M. Bryan, Anna Englezou, Jeena Gupta et al. · The EMBO Journal · 1995 · 1.3K citations · Full text
Mammalian Telomeres Resemble Fragile Sites and Require TRF1 for Efficient Replication
Agnel Sfeir, Settapong T Kosiyatrakul, Dirk Hockemeyer et al. · Cell · 2009 · 989 citations · Full text
Discovery of cancer drug targets by CRISPR-Cas9 screening of protein domains
Junwei Shi, Eric Wang, Joseph P. Milazzo et al. · Nature Biotechnology · 2015 · 787 citations · Full text